References
Charney D, Barlow D, Botteron K et al (2002) Neuroscience research agenda to guide development of a pathophysioogically based classification system. In: Kupfer D, First M, Regier D (eds) A research agenda for DSM-V. American Psychiatric Association, Washington, DC
Pinna G, Costa E, Guidotti A (2009) SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake. Curr Opin Pharmacol 9:24–30
Protopopescu X, Teuscher O, Pan H et al (2008) Toward a functional neuroanatomy of premenstrual dysphoric disorder. J Affective Disorders 108:87–94
Regier D, Narrow W, Kuhl E et al (2009) The conceptual development of DSM-V. Am J Psychiatry 166:645–650
Tanrikut C, Feldman A, Altemus M et al (2009) Adverse effect of paroxetine on sperm. Fertil Steril in press
Conflict of interest
The author declares that she received donation of study drug from Pfizer for an otherwise NIMH-funded multisite clinical trial.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Altemus, M. Hormone-specific psychiatric disorders: do they exist?. Arch Womens Ment Health 13, 25–26 (2010). https://doi.org/10.1007/s00737-009-0123-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00737-009-0123-0